» Articles » PMID: 28767911

Test-retest Reliability of Brazilian Version of Memorial Symptom Assessment Scale for Assessing Symptoms in Cancer Patients

Overview
Specialty General Medicine
Date 2017 Aug 3
PMID 28767911
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To assess the test-retest reliability of the Memorial Symptom Assessment Scale translated and culturally adapted into Brazilian Portuguese.

Methods: The scale was applied in an interview format for 190 patients with various cancers type hospitalized in clinical and surgical sectors of the Instituto Nacional de Câncer José de Alencar Gomes da Silva and reapplied in 58 patients. Data from the test-retest were double typed into a Microsoft Excel spreadsheet and analyzed by the weighted Kappa.

Results: The reliability of the scale was satisfactory in test-retest. The weighted Kappa values obtained for each scale item had to be adequate, the largest item was 0.96 and the lowest was 0.69. The Kappa subscale was also evaluated and values were 0.84 for high frequency physic symptoms, 0.81 for low frequency physical symptoms, 0.81 for psychological symptoms, and 0.78 for Global Distress Index.

Conclusion: High level of reliability estimated suggests that the process of measurement of Memorial Symptom Assessment Scale aspects was adequate.

Objetivo: Avaliar a confiabilidade teste-reteste da versão traduzida e adaptada culturalmente para o português do Brasil do Memorial Symptom Assessment Scale.

MÉtodos: A escala foi aplicada em forma de entrevista em 190 pacientes com diversos tipos de câncer internados nos setores clínicos e cirúrgicos do Instituto Nacional de Câncer José de Alencar Gomes da Silva e reaplicada em 58 pacientes. Os dados dos testes-retestes foram inseridos num banco de dados por dupla digitação independente em Excel e analisados pelo Kappa ponderado.

Resultados: A confiabilidade da escala mostrou-se satisfatória nos testes-retestes. Os valores do Kappa ponderado obtidos para cada item da escala apresentaram-se adequados, sendo o maior item de 0,96 e o menor de 0,69. Também se avaliou o Kappa das subescalas, sendo de 0,84 para sintomas físicos de alta frequência, de 0,81 para sintomas físicos de baixa frequência, de 0,81 também para sintomas psicológicos, e de 0,78 para Índice Geral de Sofrimento.

ConclusÃo: Altos níveis de confiabilidade estimados permitem concluir que o processo de aferição dos itens do Memorial Symptom Assessment Scale foi adequado.

Citing Articles

Effectiveness of Aerobic Training for Adverse Symptoms Related to Chemotherapy During Treatment: Protocol for a Randomized Controlled Trial With Cost-Effectiveness Assessment.

Selles W, Miyamoto G, Santos E, Carmo C, Moura G, Santos G JMIR Res Protoc. 2024; 13:e60828.

PMID: 39163116 PMC: 11372328. DOI: 10.2196/60828.


Cancer symptom clusters, cardiovascular risk, and quality of life of patients with cancer undergoing chemotherapy: A longitudinal pilot study.

Nunes K, Grippa W, Lopes A, Gomes K, Grassi J, Neto L Medicine (Baltimore). 2024; 103(16):e37819.

PMID: 38640317 PMC: 11029927. DOI: 10.1097/MD.0000000000037819.


Factors Associated with the Quality of Life among Family Caregivers of Cholangiocarcinoma Survivors in Northeastern Thailand.

Summart U, Sangruangake M, Songthamwat M, Wittayapun Y, T Teinprasert S, Chaplik N Asian Pac J Cancer Prev. 2023; 24(4):1249-1255.

PMID: 37116147 PMC: 10352748. DOI: 10.31557/APJCP.2023.24.4.1249.


The Relationship between Unmet Need, Physical Symptoms, Psychological Well-Being and Health-Related Quality of Life in Cholangiocarcinoma Survivors.

Sangruangake M, Summart U, Songthamwat M, Sangchart B Asian Pac J Cancer Prev. 2022; 23(8):2821-2828.

PMID: 36037139 PMC: 9741894. DOI: 10.31557/APJCP.2022.23.8.2821.


Symptom Prevalence in Spanish and Colombian Oncology Patients Measured with the MSAS.

Llamas-Ramos I, Llamas-Ramos R, Carrillo-Gonzalez G, Sepulveda-Ramirez J, Vargas-Rosero E Cancers (Basel). 2022; 14(7).

PMID: 35406396 PMC: 8996859. DOI: 10.3390/cancers14071624.


References
1.
Portenoy R, Thaler H, Kornblith A, Lepore J, Kiyasu E, Sobel K . The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994; 30A(9):1326-36. DOI: 10.1016/0959-8049(94)90182-1. View

2.
Browall M, Kenne Sarenmalm E, Nasic S, Wengstrom Y, Gaston-Johansson F . Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress. J Pain Symptom Manage. 2012; 46(1):131-41. DOI: 10.1016/j.jpainsymman.2012.07.023. View

3.
Campos M, Leal M, Souza Jr P, Cunha C . [Consistency between data sources and inter-observer reliability in the Study on Neonatal and Perinatal Morbidity and Mortality and Care in the City of Rio de Janeiro]. Cad Saude Publica. 2006; 20 Suppl 1:S34-43. DOI: 10.1590/s0102-311x2004000700004. View

4.
Pud D . The psychometric properties of the Hebrew version of the Memorial Symptom Assessment scale (MSAS-Heb) in patients with breast cancer. J Pain Symptom Manage. 2014; 49(4):790-5. DOI: 10.1016/j.jpainsymman.2014.08.016. View

5.
Reichenheim M, Moraes C . [Operationalizing the cross-cultural adaptation of epidemiological measurement instruments]. Rev Saude Publica. 2007; 41(4):665-73. DOI: 10.1590/s0034-89102006005000035. View